Bellevue Group AG - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$888,030
-10.6%
33,0000.0%0.01%0.0%
Q2 2023$993,630
-6.9%
33,0000.0%0.01%
-6.7%
Q1 2023$1,067,550
+102.4%
33,000
+79.3%
0.02%
+114.3%
Q4 2022$527,344
+63.3%
18,400
+37.3%
0.01%
+40.0%
Q3 2022$323,000
-12.0%
13,4000.0%0.01%0.0%
Q2 2022$367,000
-28.6%
13,4000.0%0.01%
-16.7%
Q1 2022$514,00013,4000.01%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2023
NameSharesValueWeighting ↓
New Harbor Financial Group, LLC 1,221,955$36,011,00014.81%
New Harbor Financial Group, LLC 1,155,900$34,064,00014.01%
Memorial Sloan Kettering Cancer Center 738,500$21,764,00013.56%
Hollow Brook Wealth Management LLC 670,275$19,753,00012.24%
Grand Central Investment Group 293,243$8,642,00011.46%
BW Gestao de Investimentos Ltda. 940,800$27,725,0008.44%
Slate Path Capital LP 5,930,000$174,757,0007.97%
Nokomis Capital, L.L.C. 512,628$15,107,0007.14%
Plaisance Capital LLC 288,000$8,487,0006.05%
Guild Investment Management, Inc. 200,114$5,897,0005.68%
View complete list of VANECK VECTORS ETF TR shareholders